News
MRS Partners with the Montage Healthcare to Enrich Mammography Quality Efforts
February 12th, 2013
Mammography Reporting System, Inc. (MRS) of Seattle, Washington and Montage Healthcare of Philadelphia, PA, today announced that the companies have signed a business partnership that will provide Montage’s analytics tool to MRS customers, as well as enable MRS to resell the Montage Search and AnalyticsTM solution.
MRS users can now utilize the Montage search-driven capability to mine the structured and unstructured clinical information stored in the MRS system. Mammography quality improvement efforts will benefit by the ability to correlate the rich mammography specific clinical data with related clinical findings. A radiologist using Montage to uncover clinical information that aids diagnosis will benefit from access to historical report information, as will clinical quality managers looking to understand the relationship between imaging protocols, clinical findings, therapy and outcomes.
“Breast imaging already receives a significant clinical quality scrutiny, because of the Mammography Quality Standards Act (MSQA). Including Montage data mining and analysis, to existing MRS capabilities, provides caregivers exciting opportunities to further enhance breast imaging quality across the imaging modality spectrum,” says William Boonn, MD, President of Montage Healthcare Solutions. “We are excited to partner with MRS, an industry leader in the field of breast imaging quality management and reporting.” MRS currently provides numerous breast imaging specific reporting, quality assurance and risk management tools that help facilities meet stringent MSQA and ACR accreditation standards. “We recognized that Montage Healthcare shares the vision of not only MRS but also our customers for continuous clinical quality improvement, whether mandated or not,” says Mark P. Morris, CEO at Mammography Reporting Systems. “We feel strongly that our partnership will enable our customers to more comprehensively manage their clinical quality improvement efforts, through not only the existing MRS database reporting functions but also the sophisticated analysis tools Montage has developed.”
MRS Now Offers Compass Computer-Aided Breast MRI Software
October 9th, 2012
MRS, leader in tracking and reporting for breast-related procedures, expands its breast health software portfolio with the Compass computer-aided analysis software application for improved efficiency and economics in breast MRI. Compass, now used by an ever-growing number of breast imaging programs nationwide, delivers real-time visualization and flexibility providing radiologists with the time-sensitive information needed to maximize productivity when interpreting and reporting complex studies. As a cost-effective computer-aided analysis breast MRI application, Compass features include image registration, subtractions, multiplanar reformatting, MIPs, Angiogenesis Maps and curves, volume analysis and customizable hanging layouts.
MRS Receives Health Tech Impact Award From The Seattle Business Magazine
September 27th, 2012
Seattle Business Magazine, together with the Washington Technology Industry Association (WTIA), today honored Mammography Reporting System with the 2012 silver Healthcare Tech Impact Award. The Seattle Business Magazine’s Tech Impact Awards program recognizes companies and individuals that are creating or using information technology in new and innovative ways to significantly improve a company or industry’s business performance or to provide an important public benefit.
With over 25 year in business, Mammography Reporting System (MRS) is recognized as the industry pioneer for software designed to track and report breast-related procedures. MRS systems are designed to promote operational efficiency, improved financial performance, and quality patient care in any sized facility. MRS is trusted by over 2,500 facilities nation-wide, and is the largest provider of breast tracking and reporting solutions. MRS is constantly innovating by investing heavily in research and development in order to provide state-of-the-art solutions that meet and exceed the rapidly evolving technological and industry standards of healthcare.
MRS Signs Business Partnership with Oncology OnTrack by Priority Consult
July 12th, 2012
Mammography Reporting System, Inc. (MRS) of Seattle, Washington and Priority Consult, LLC of Cincinnati, Ohio, today announced that the companies have signed a business partnership agreement. The combination of MRS’s robust patient communication package with Priority Consult’s advanced Oncology OnTrack patient tracking system will positively impact the quality of breast-health patient tracking for facilities that utilize both systems.
The two companies have recently completed a major overhaul on their software interface that connects MRS’s mammography tracking and reporting system to the Oncology OnTrack patient navigation program. The new interface delivers more comprehensive patient information from MRS to Oncology OnTrack, which improves the quality of breast-health patient tracking. The collaboration between MRS and Priority Consult’s Oncology OnTrack patient navigation program offers MRS customers the most advanced patient navigation system available.
The interface between MRS and Oncology OnTrack is designed to provide medical professionals with the tools they need to ensure optimal patient care from screening to survivorship. Facilities using MRS and Priority Consult can now benefit from enhanced communication that supports improved patient management for post screening or diagnostic imaging. MRS supports patient tracking by collecting and storing a larger volume of relevant patient data such as family history, procedure history, risk factors, and patient demographics.
“Oncology OnTrack and MRS are a great operational fit for facilities that want to experience the truly best-of-breed solution in both navigation and breast imaging tracking and reporting,” said Mark Morris, CEO of MRS. “Our clients have found that the best integration between vendors, like this integration between Priority Consult’s Oncology OnTrack patient navigation program and MRS, increases facility reliability and efficiency. This makes for improved satisfaction from patients, more effective and efficient staff, and improved bottom lines.”
MRS and Matakina Sign Agreement to Display Volpara® Breast Density Results on MRS7
June 13th, 2012
Matakina International Limited of Wellington, New Zealand, and Mammography Reporting System, Inc. (MRS) of Seattle, Washington, today announced that the companies have signed an agreement that allows MRS to provide users of the MRS7 Reporting System with the ability to utilize the Volpara® breast density software scores in an updated User Interface. This agreement also grants MRS the rights to distribute Volpara® software.
The Volpara® breast density software is FDA-cleared product that offers radiologists a reliable and cost-effective tool to automatically generate objective volumetric breast tissue density values from digital screening mammograms. Volpara® automatically generates objective, automatic measurement of volumetric breast density values under the Volpara Density Grade (VDG®) – a refined grading system which correlates with the American College of Radiology BI-RADS® Density Grading Classifications. Integrations of Volpara® with other digital mammography and CAD systems are also underway.
“The objective measurement of breast density clearly offers important clinical information to improve the early detection of breast cancer, but the technology cannot be used effectively unless it is easily integrated into routine diagnostic workflow,” said Dr. Ralph Highnam, CEO, Matakina International, Ltd. “MRS is a proven leader in providing access to critical breast health information. The ability to display Volpara results on the MRS mammography workstation is another important milestone in widespread access to objective breast density values.”
Breast tissue density has been linked to an increased risk of breast cancer. Several large studies have confirmed that as tissue density increases, the accuracy of lesion detection through mammography decreases. Thirty-five percent of breast cancer goes undetected by mammography in women with dense breasts, as density masks the appearance of tumors (Boyd et al 2007, NEJM). Since both dense breast tissue and cancer appear white on a mammogram, finding cancers can be analogous to looking for a snowball in a snowstorm.
“We are pleased to establish a partnership with Matakina® to make Volpara® breast density software available to thousands of facilities that use MRS reporting and tracking systems,” said Mark Morris, CEO of MRS. “Adding Volpara® scores directly into the MRS7 Reporting System supports our mission of providing timely, relevant information that incorporates directly into the radiologist reporting workflow. Our customers have found that, providing radiologists with concurrent access to clinically relevant diagnostic information helps improve the overall quality of patient care while achieving time and cost savings for the radiologist.”
